NCT00742365

Brief Summary

This study will evaluate a possible tool for predicting future effectiveness of bright light in treating seasonal affective disorder, winter subtype, and will examine secondary effects of bright light on cardiovascular risk factors.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2007

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 27, 2008

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
Last Updated

November 21, 2019

Status Verified

November 1, 2019

Enrollment Period

2.4 years

First QC Date

August 25, 2008

Last Update Submit

November 19, 2019

Conditions

Keywords

Seasonal Affective DisorderLight TherapySeasonal DepressionPsychiatric DisorderBright LightMajor Depressive DisorderBipolar Disorder

Outcome Measures

Primary Outcomes (1)

  • Hamilton rating scale for depressional seasonal affective disorder (SIGH SAD)

    Measured at baseline, 1 hour after light treatment, and weekly for 6 weeks

Secondary Outcomes (8)

  • Hunger questionnaire

    Measured daily for 6 weeks

  • Three factor eating questionnaire

    Measured weekly for 6 weeks

  • Sleep log

    Measured weekly for 6 weeks

  • Food craving questionnaire

    Measured daily for 6 weeks

  • Side effects questionnaire

    Measured weekly for 6 weeks

  • +3 more secondary outcomes

Study Arms (2)

A

Participants will be given a 1-hour lab test of bright light treatment, then the bright light treatment for 6 weeks.

Device: Bright light

B

Participants will be given a 1-hour treatment of the red light placebo, then the bright light treatment for 6 weeks.

Device: Red light placebo

Interventions

One hour of exposure to bright light daily upon awakening for 6 weeks.

Also known as: Brite light III light box (Apollo) 10,000 lux.
A

One hour of exposure to red light.

Also known as: Dim red light box (Apollo) 50 lux.
B

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with history of recurrent winter depression

You may qualify if:

  • Current major depressive disorder, by structured diagnostic interview (SCID), or current bipolar II disorder, if no prior history of rapid cycling, by SCID
  • Prior history of major depressive disorder or bipolar II disorder with seasonal specifier, by SCID
  • Score of 21 or greater on Hamilton Rating Scale for Depression - Seasonal Affective Disorder Version (SIGH-SAD), met at three time points (informed consent session, 24 hours prior to first light therapy session, and at first light therapy session)

You may not qualify if:

  • Current bipolar I disorder, psychotic disorder, or cognitive disorder, by SCID
  • Illicit drug use in the past year, by self-report, or alcohol abuse by SCID
  • History of systemic lupus erythematosus
  • History of heart attack or stroke
  • No antidepressant, mood stabilizer, or antipsychotic medication treatment 30 days before treatment
  • Current occupation involves shift work
  • Current sensitivity to bright light or vision problems not correctable by glasses, by self-report
  • Inability to distinguish colors or see stars at night because of increased light sensitivity, by self-report
  • Current suicidal ideation, by self-report during SCID interview
  • Women of childbearing potential who are pregnant, nursing, or trying to become pregnant. Female participants of childbearing potential must agree to one of the following types of birth control: oral, transdermal, or implantable hormonal contraceptives; intrauterine device; diaphragm plus spermicide; or female condom plus spermicide.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Uzoma HN, Reeves GM, Langenberg P, Khabazghazvini B, Balis TG, Johnson MA, Sleemi A, Scrandis DA, Zimmerman SA, Vaswani D, Nijjar GV, Cabassa J, Lapidus M, Rohan KJ, Postolache TT. Light treatment for seasonal Winter depression in African-American vs Caucasian outpatients. World J Psychiatry. 2015 Mar 22;5(1):138-46. doi: 10.5498/wjp.v5.i1.138.

    PMID: 25815263BACKGROUND
  • Reeves GM, Rohan KJ, Langenberg P, Snitker S, Postolache TT. Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes. J Affect Disord. 2012 Apr;138(1-2):123-7. doi: 10.1016/j.jad.2011.12.003. Epub 2012 Jan 25.

    PMID: 22277151BACKGROUND
  • Reeves GM, Nijjar GV, Langenberg P, Johnson MA, Khabazghazvini B, Sleemi A, Vaswani D, Lapidus M, Manalai P, Tariq M, Acharya M, Cabassa J, Snitker S, Postolache TT. Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. J Nerv Ment Dis. 2012 Jan;200(1):51-5. doi: 10.1097/NMD.0b013e31823e56ca.

    PMID: 22210362BACKGROUND
  • Virk G, Reeves G, Rosenthal NE, Sher L, Postolache TT. Short exposure to light treatment improves depression scores in patients with seasonal affective disorder: A brief report. Int J Disabil Hum Dev. 2009 Jul;8(3):283-286. doi: 10.1901/jaba.2009.8-283.

    PMID: 20686638BACKGROUND

MeSH Terms

Conditions

DepressionSeasonal Affective DisorderMental DisordersDepressive Disorder, MajorBipolar Disorder

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersBipolar and Related Disorders

Study Officials

  • Teodor T. Postolache, MD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 25, 2008

First Posted

August 27, 2008

Study Start

November 1, 2007

Primary Completion

April 1, 2010

Study Completion

August 1, 2010

Last Updated

November 21, 2019

Record last verified: 2019-11